Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

Historical Holders from Q3 2021 to Q1 2025

Symbol
CTKB on Nasdaq
CUSIP
23285D109
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
77.2M
Holdings value
$501M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
149
Number of buys
81
Number of sells
-57
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.3% $74.1M 18.5M BlackRock, Inc. Dec 31, 2024

Institutional Holders of Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 519K $2.08M +$222K $4.01 15
2024 Q4 77.2M $501M +$11.9M $6.49 149
2024 Q3 75M $415M -$14.6M $5.54 134
2024 Q2 76.2M $425M -$33.2M $5.58 126
2024 Q1 76.2M $511M +$11.7M $6.71 90
2023 Q4 78.9M $720M +$15.9M $9.12 101
2023 Q3 77.5M $428M -$4.04M $5.52 107
2023 Q2 77M $658M +$70M $8.54 100
2023 Q1 68.5M $630M +$39.2M $9.19 99
2022 Q4 64M $654M +$18.3M $10.21 99
2022 Q3 60.8M $895M +$128M $14.72 84
2022 Q2 52.9M $567M +$55.4M $10.73 80
2022 Q1 47.6M $513M +$121M $10.78 71
2021 Q4 35M $572M +$5.77M $16.32 51
2021 Q3 34.4M $744M +$744M $21.41 52